everblu capital – 29 april 2019, page-24

$28m cashflow from investing was listed.

Disclaimer was as follows:

*** Includes the costs of operating the mine and processing facilities, and other cash costs relating to the sale of spodumene concentrate during commissioning and ramp-up of the mining operation. These costs are classified as cash flows from investing activities until such time as commercial production is declared and are capitalised against project development costs (net of the sales of spodumene concentrate (pre-production) referred to above).

Doesn't say financing costs.

Only other bulk expenditure that was listed was capex.

If you take interest costs out of that $28m figure it means they produced 30kt for around $15m. Cash costs of A$500. If they did that then they are looking quite good. I am sceptical though?

I dunno?